Janssen Seeks European Marketing Authorization For Investigational Hepatitis C Treatment Telaprevir
Links shared publicly online about this topic.
- 641total visits
Janssen Seeks European Marketing Authorization For Investigational Hepatitis C Treatment Telaprevir
View full resource at medicalnewstoday.com
Tags: Liver, Liver Condition, Hepatitis, Hepatitis C, Telaprevir
Most Recently Shared on December 20, 2010 at 2:05 pm By:
Janssen Seeks European Marketing Authorization For Investigational Hepatitis C Treatment Telaprevir http://mnt.to/3PhN #liver #hepatitis
Janssen Seeks European Marketing Authorization For Investigational Hepatitis C Treatment Telaprevir - QualityPoint Technologies
qualitypointtech.net — “Janssen-Cilag International NV announced the submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for telaprevir, an investigational, oral, direct-acting antiviral for the treatment of chronic genotype 1 hepatitis C virus (HCV), the most common form of the virus...” View full resource at qualitypointtech.net
Most Recently Shared on December 20, 2010 at 1:00 pm By:
Janssen Seeks European Marketing Authorization For Investigational Hepatitis C Treatment Telaprevir: Janssen-Cilag... http://bit.ly/eVSVUg
Advertisement
